ESMO issues guidance about biomarker testing, researchers break down coronavirus risk by cancer type, and the FDA approves liquid biopsy test across tumor types.

by Marci A. Landsmann

Blood cancer patients have low rates of enrollment in hospice. One barrier to enrollment is that many hospices do not provide blood transfusions.

by Jon Kelvey

A combination of targeted therapies may be effective in people with bile duct cancers, and recent chemotherapy is not associated with worse outcomes from COVID-19.

by Kate Yandell

Despite national guidelines urging oncologists to bring up risks of infertility posed by cancer treatment, many young cancer patients are never told about these risks or counseled on their fertility preservation options.

by Marcus A. Banks

Lung cancer death rates are on the decline, and a daughter mourns her mother's death from cancer during the pandemic.

by Marci A. Landsmann

Study underscores importance of early detection and prevention.

by Jane Langille

A study shows that new cancer diagnoses declined in March and April 2020, and the Food and Drug Administration approves a treatment for multiple myeloma.

by Kate Yandell

Doctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward.

by Kate Yandell